Evaluation of Tuberculosis Treatment Outcome of TB/HIV Co-Infection: A Four-Year Retrospective Cohort Study in HIV-Prevalent Setting of North Central Nigeria
Background: Despite the availability of highly effective treatment for decades, Tuberculosis (TB) remains a major health problem in Nigeria due to the increasing association between HIV and TB observed over the past three decades when HIV was discovered. However, the proportion of TB and or TB/HIV co-infected patients who have successful TB treatment outcome is not well known. This study determined the treatment outcome of TB/HIV co-infected patients with HIV negative patients in two states in Nigeria. Materials and Methods: A retrospective study of secondary data from eight Directly Observed Treatment Short (DOTS) course and Anti- Retroviral Therapy (ART) service providers in Benue and Federal Capital Territory (FCT), Nigeria, was carried out. The period under review covers January, 2010 to December, 2013. Results: Out of the total 5266 TB cases reviewed, the HIV prevalence rate was 52%. They were predominantly (53.3%) male with mean age of 34.4 years (SD = 15.1 years). More than two-third (72.5%) of HIV-negative patients had successful treatment compared to 1718 (62.7%) HIV-positive patients. Of the 2334 HIV co-infected patients, 19.5% defaulted, 11.5% had died, 5.6% were transferred out and 0.7% failed treatment compared to HIV-negative patients amongst whom 18.3% defaulted, 3.6% died, 3.9% were transferred out and 1.6% failed treatment (p < 0.05). TB/HIV co-infected patients with baseline CD4 of ≥300 cell/mm3 are more likely to have successful treatment outcome {OR-1.541 (95% CI = 1.030 - 2.305) p = 0.035}. Patients ≥45 years old and those not on Co-trimoxazole Preventive Therapy (CPT) are more likely to have unsuccessful treatment outcome {OR-1.022 (95% CI = 0.643 - 1.488) p = 0.918 and OR-1.306 (95% CI = 0.956 - 1.555) respectively. Conclusion: The favourable treatment outcome of HIV-negative patients is more than that of HIV-positive patients and the most probable predictable factor responsible is the CD4 count of patient; indicating that TB/HIV co-infection has remained a major public health problem in Benue state and FCT. Hence there is the need for sustained strengthening and expansion of the national TB/HIV programmes.
References
[1]
World Health Organization (2012) Global Report for Research on Infectious Diseases of Poverty. www.who.int
[2]
WHO (2013) Global Tuberculosis Report, 2013. WHO, Geneva. www.who.int/tb/data
[3]
Mekdes, K.G., Gunnar, A.B. and Jan, C.F. (2010) Barriers and Facilitators of Adherence to TB Treatment in Patients on Concomitant TB and HIV Treatment: A Qualitative Study. BMC Public Health, 10, 651.
[4]
WHO encyclopedia.com. Worldmark Encyclopedia of Nations, 2007. www.who.int/tb/data
[5]
WHO Report 2008. Global Tuberculosis Control: Surveillance, Planning, Financing.
www.who.int
[6]
Global Tuberculosis Report 2014. www.who.int
[7]
United State Embassy in Nigeria (2014) Nigeria Tuberculosis Fact Sheet 2012.
http://nigeria.usembassy.gov
[8]
Lawson, L., Yassin, M.A., Thacher, T.D., Olatunji, O.O., Lawson, J.O., Akingbogun, T.I., et al. (2008) Clinical Presentation of Adults with Pulmonary Tuberculosis with and without HIV Infection in Nigeria. Scandinavian Journal of Infectious Diseases, 40, 30-35.
http://dx.doi.org/10.1080/00365540701509899
[9]
Jamda, M.A., Lawson, L., Nnodu, O.O., Ajani, M.N., Umobong, E.O., Fredrick, C.C., et al. (2014) Treatment Outcome of Patients Co-Infected with Tuberculosis and HIV in Abuja, Nigeria. Nigerian Journal of Basic and Clinical Sciences, 11, 72-75.
[10]
Jemikalajah, J.D. and Okogun, G.A. (2008) Health Point Prevalence of Human Immunodeficiency Virus and Pulmonary Tuberculosis among Patients in Various Parts of Delta State, Nigeria. Saudi Medical Journal, 30, 387-391.
[11]
Pennap, G., Makpa, S. and Ogbu, S. (2010) Sero-Prevalence of HIV Infection among Tuberculosis Patients in a Rural Tuberculosis Referral Clinic in Northern Nigeria. The Pan African Medical Journal, 5, 22.
[12]
National Population Commission, Nigeria Facts and Figures 2006 Census.
http://www.population.gov.ng
[13]
Ige, O.M. and Oladokun, R.E. (2011) Treatment Outcome of Newly Diagnosed Sputum Positive Adult Tuberculosis Cases in the Context of HIV Infection. Journal of Infectious Disease and Immunity, 3, 210-217.
[14]
Dauda, M. (2010) Evaluation of the Efficacy of Directly Observed Treatment Short Course (DOTS) in Patients with Tuberculosis and HIV Infection in Kano, Nigeria. RIF, 1, 218-223.
[15]
Range, N., Ipuge, Y.A., O’Brien, R.J., Egwagab, S.M., Mfinanga, S.G., Chonde, T.M., et al. (2001) Trend in HIV Prevalence among Tuberculosis Patients in Tanzania, 1991-1998. The International Journal of Tuberculosis and Lung Disease, 5, 405-412.
[16]
Bruchfeld, J., Aderaye, G., Palme, I.B. and Bjorvatn, B. (2002) Evaluation of Outpatients with Suspected Pulmonary Tuberculosis in a High HIV Prevalence Setting in Ethiopia: Clinical, Diagnostic and Epidemiological Characteristics. Scandinavian Journal of Infectious Diseases, 34, 331-337. http://dx.doi.org/10.1080/00365540110080025
[17]
Federal Ministry of Health [Nigeria] (2013) National HIV & AIDS and Reproductive Health Survey, 2012 (NARHS Plus). Federal Ministry of Health Abuja, Nigeria.
[18]
Yassin, M.A., Datiko, D.G. and Shargie, E.B. (2006) Ten Year Experiences of Tuberculosis Control Programme in the Southern Region of Ethiopia. The International Journal of Tuberculosis and Lung Disease, 10, 1166-1171.